ArticleDrug design, development and therapy2022

Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.

Jiangbo Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.